Improving breast cancer multidisciplinary meetings through streamlining with protocol-based management

TY - JOUR

T1 - Improving breast cancer multidisciplinary meetings through streamlining with protocol-based management

AU - Sinha, Aaditya Prakash

AU - Badawy, Katie

AU - Shifa, Belul

AU - Peterson, Zhane

AU - Attia, Mohamed

AU - Pinder, Sarah

AU - Purushotham, Arnie

N1 - Publisher Copyright: © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2024/9/24

Y1 - 2024/9/24

N2 - Objectives Multidisciplinary meetings (MDMs) are part of standard of care for patients with cancer. Streamlining is essential for high-quality care and efficiency. This study evaluated the feasibility of implementing a protocol to remove patients with benign breast disease from discussion at the MDM. Methods A prospective review of 218 MDMs evaluated patients with benign breast disease over 22 months. This was followed by a protocol implementation phase over 54 MDMs (6.5 months). Patients meeting specific criteria were excluded from discussion. Results On average, each MDM consisted of 37 patients, 34.2% of whose conditions were benign and potentially could have been removed from discussion. The implementation phase showed 708/2248 patients (32.5%) were benign of which 631 cases (89%) met the eligibility criteria and were removed from the MDM list allowing more time for discussion of complex cases. Conclusion Implementing a protocol can safely exclude patients with benign disease from MDM discussion.

AB - Objectives Multidisciplinary meetings (MDMs) are part of standard of care for patients with cancer. Streamlining is essential for high-quality care and efficiency. This study evaluated the feasibility of implementing a protocol to remove patients with benign breast disease from discussion at the MDM. Methods A prospective review of 218 MDMs evaluated patients with benign breast disease over 22 months. This was followed by a protocol implementation phase over 54 MDMs (6.5 months). Patients meeting specific criteria were excluded from discussion. Results On average, each MDM consisted of 37 patients, 34.2% of whose conditions were benign and potentially could have been removed from discussion. The implementation phase showed 708/2248 patients (32.5%) were benign of which 631 cases (89%) met the eligibility criteria and were removed from the MDM list allowing more time for discussion of complex cases. Conclusion Implementing a protocol can safely exclude patients with benign disease from MDM discussion.

KW - Disease Management

KW - Secondary Care

UR - https://www.scopus.com/pages/publications/85204942322

U2 - 10.1136/bmjhci-2023-100949

DO - 10.1136/bmjhci-2023-100949

M3 - Article

C2 - 39317463

AN - SCOPUS:85204942322

SN - 2632-1009

VL - 31

JO - BMJ Health and Care Informatics

JF - BMJ Health and Care Informatics

IS - 1

M1 - e100949

ER -